Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Remimazolam for Remifentanil-induced Hyperalgesia in Urologic Surgery
NCT05866315Completed
- Sponsor
- Wonkwang University Hospital
- Start
- May 2023
- Primary completion
- Sep 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, single-blind trial of remimazolam in opioid-induced hyperalgesia (OIH) (3 arms), sponsored by Wonkwang University Hospital. Primary endpoint: The mechanical hyperalgesia threshold. Started May 2023; status: completed.
02
Drugs
remimazolam
03
Conditions
opioid-induced hyperalgesia (OIH)
Beyond the preview
Go deeper on NCT05866315.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05866315.